Skip to main content
Erschienen in: International Urogynecology Journal 3/2005

01.06.2005 | Original Article

Predictive value of prolapse symptoms: a large database study

verfasst von: Jasmine S. Tan, Emily S. Lukacz, Shawn A. Menefee, Curt R. Powell, Charles W. Nager, San Diego Pelvic Floor Consortium

Erschienen in: International Urogynecology Journal | Ausgabe 3/2005

Einloggen, um Zugang zu erhalten

Abstract

We sought to describe the relationship between patient symptoms and pelvic organ prolapse (POP) and report the sensitivity, specificity, and positive and negative predictive value of these POP symptoms. Two urologists and four urogynecologists developed a standardized pelvic floor questionnaire based on face validation for use at three female pelvic floor disorder clinics. Specific questions related to prolapse included questions on urinary splinting, digital assistance for defecation, and a bulge per vagina. Prolapse was assessed with the standardized Pelvic Organ Prolapse Quantitative (POP-Q) terminology. The analysis included 1912 women. Urinary splinting was uncommon (<10%) when Ba <0, but ranged between 23 and 36% for stage III and IV Ba prolapse. Digital assistance was equally common in stage II Bp prolapse (21–38%) and stage III-IV Bp prolapse (26–29%). Only 6–11% of women with stage 0 or I POP reported symptoms of bulge, but with stage II it increased to 77%. Urinary splinting is 97% specific for anterior prolapse. The report of a bulge has an 81% positive predictive value and a 76% negative predictive value. Very few patients without anterior prolapse will report urinary splinting. Digital assistance for fecal evacuation is no more common with massive posterior prolapse than with moderate posterior prolapse. Patient report of a bulge is a valuable screening tool for POP and should prompt a careful exam.
Literatur
1.
Zurück zum Zitat Peterson M, Holbrook JH, Von Hales D et al (1992) Contributions of the history, physical examination, and laboratory investigation in making medical diagnoses. West J Med 156:163–165PubMed Peterson M, Holbrook JH, Von Hales D et al (1992) Contributions of the history, physical examination, and laboratory investigation in making medical diagnoses. West J Med 156:163–165PubMed
2.
Zurück zum Zitat Hampton JR, Harrison MJ, Mitchell JR, Prichard JS, Seymour C (1975) Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J 2:486–489PubMed Hampton JR, Harrison MJ, Mitchell JR, Prichard JS, Seymour C (1975) Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J 2:486–489PubMed
3.
Zurück zum Zitat Jensen JK, Nielsen FR Jr, Ostergard DR (1994) The role of patient history in the diagnosis of urinary incontinence. Obstet Gynecol 83:904–910PubMed Jensen JK, Nielsen FR Jr, Ostergard DR (1994) The role of patient history in the diagnosis of urinary incontinence. Obstet Gynecol 83:904–910PubMed
4.
Zurück zum Zitat Melville JL, Miller EA, Fialkow MF et al (2003) Relationship between patient report and physician assessment of urinary incontinence severity (miscellaneous article). Am J Obstet Gynecol 189:76–80PubMed Melville JL, Miller EA, Fialkow MF et al (2003) Relationship between patient report and physician assessment of urinary incontinence severity (miscellaneous article). Am J Obstet Gynecol 189:76–80PubMed
5.
Zurück zum Zitat Thakar R, Stanton S (2002) Regular review: management of genital prolapse. BMJ 324:1258–1262PubMed Thakar R, Stanton S (2002) Regular review: management of genital prolapse. BMJ 324:1258–1262PubMed
6.
Zurück zum Zitat Spence-Jones C, Kamm MA, Henry MM, Hudson CN (1994) Bowel dysfunction: a pathogenic factor in uterovaginal prolapse and urinary stress incontinence. Br J Obstet Gynaecol 101:147–152PubMed Spence-Jones C, Kamm MA, Henry MM, Hudson CN (1994) Bowel dysfunction: a pathogenic factor in uterovaginal prolapse and urinary stress incontinence. Br J Obstet Gynaecol 101:147–152PubMed
7.
Zurück zum Zitat Zbar AP, Lienemann A, Fritsch H, Beer-Gabel M, Pescatori M (2003) Rectocele: pathogenesis and surgical management. Int J Colorectal Dis 18:369–384CrossRefPubMed Zbar AP, Lienemann A, Fritsch H, Beer-Gabel M, Pescatori M (2003) Rectocele: pathogenesis and surgical management. Int J Colorectal Dis 18:369–384CrossRefPubMed
8.
Zurück zum Zitat Fialkow MF, Gardella C, Melville J et al (2002) Posterior vaginal wall defects and their relation to measures of pelvic floor neuromuscular function and posterior compartment symptoms. Am J Obstet Gynecol 187:1443–1449PubMed Fialkow MF, Gardella C, Melville J et al (2002) Posterior vaginal wall defects and their relation to measures of pelvic floor neuromuscular function and posterior compartment symptoms. Am J Obstet Gynecol 187:1443–1449PubMed
9.
Zurück zum Zitat Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 3:291–306PubMed Shumaker SA, Wyman JF, Uebersax JS, McClish D, Fantl JA (1994) Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 3:291–306PubMed
10.
Zurück zum Zitat Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17PubMed Bump RC, Mattiasson A, Bo K, Brubaker LP, DeLancey JO, Klarskov P, Shull BL, Smith AR (1996) The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol 175:10–17PubMed
11.
Zurück zum Zitat Weber AM, Abrams P, Brubaker L et al (2001) The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 12:178–186PubMed Weber AM, Abrams P, Brubaker L et al (2001) The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 12:178–186PubMed
12.
Zurück zum Zitat Ellerkmann RM, Cundiff GW, Melick CF et al (2001) Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 185:1332–1338PubMed Ellerkmann RM, Cundiff GW, Melick CF et al (2001) Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol 185:1332–1338PubMed
13.
Zurück zum Zitat Bump RC, Fantl JA, Hurt WG (1988) The mechanism of urinary continence in women with severe uterovaginal prolapse: results of barrier studies. Obstet Gynecol 72:291–295PubMed Bump RC, Fantl JA, Hurt WG (1988) The mechanism of urinary continence in women with severe uterovaginal prolapse: results of barrier studies. Obstet Gynecol 72:291–295PubMed
14.
Zurück zum Zitat Barber MD, Cundiff GW, Weidner AC et al (1999) Accuracy of clinical assessment of paravaginal defects in women with anterior vaginal wall prolapse. Am J Obstet Gynecol 181:87–90PubMed Barber MD, Cundiff GW, Weidner AC et al (1999) Accuracy of clinical assessment of paravaginal defects in women with anterior vaginal wall prolapse. Am J Obstet Gynecol 181:87–90PubMed
15.
Zurück zum Zitat Weber AM, Walters MD, Ballard LA et al (1998) Posterior vaginal prolapse and bowel function. Am J Obstet Gynecol 179:1446–1449; discussion 1449–1450PubMed Weber AM, Walters MD, Ballard LA et al (1998) Posterior vaginal prolapse and bowel function. Am J Obstet Gynecol 179:1446–1449; discussion 1449–1450PubMed
16.
Zurück zum Zitat Nygaard I, Bradley C, Brandt D (2004) Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 104:489–497PubMed Nygaard I, Bradley C, Brandt D (2004) Pelvic organ prolapse in older women: prevalence and risk factors. Obstet Gynecol 104:489–497PubMed
Metadaten
Titel
Predictive value of prolapse symptoms: a large database study
verfasst von
Jasmine S. Tan
Emily S. Lukacz
Shawn A. Menefee
Curt R. Powell
Charles W. Nager
San Diego Pelvic Floor Consortium
Publikationsdatum
01.06.2005
Verlag
Springer-Verlag
Erschienen in
International Urogynecology Journal / Ausgabe 3/2005
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI
https://doi.org/10.1007/s00192-004-1243-8

Weitere Artikel der Ausgabe 3/2005

International Urogynecology Journal 3/2005 Zur Ausgabe

Blutdrucksenkung könnte Uterusmyome verhindern

Frauen mit unbehandelter oder neu auftretender Hypertonie haben ein deutlich erhöhtes Risiko für Uterusmyome. Eine Therapie mit Antihypertensiva geht hingegen mit einer verringerten Inzidenz der gutartigen Tumoren einher.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.